Gene · 5817
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma. | Leukemia | 2024 | 39322713 | PubTator, text mining | PubMed |
| Polymeric immunoglobulin receptor promotes Th2 immune response in the liver by increasing cholangiocytes derived IL-33: a diagnostic and therapeutic biomarker of biliary atresia. | EBioMedicine | 2024 | 39288533 | PubTator, text mining | PubMed |
| Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer. | J Transl Med | 2024 | 39267111 | PubTator, text mining | PubMed |
| Relationship between TIGIT expression on T cells and the prognosis of patients with hepatocellular carcinoma. | BMC Cancer | 2024 | 39251968 | PubTator, text mining | PubMed |
| Chitosan/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo/immuno-resistance in unresectable metastatic melanoma. | Carbohydr Polym | 2024 | 39245506 | PubTator, text mining | PubMed |
| SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis-Associated Tumor Cells by Remodeling the Lymph Node Microenvironment. | Adv Sci (Weinh) | 2024 | 39236316 | PubTator, text mining | PubMed |
| Whole exome sequencing identifies genetic markers of enterovirus susceptibility in East Asians. | Front Microbiol | 2024 | 39234544 | PubTator, text mining | PubMed |
| OMIP-106: A 30-color panel for analysis of check-point inhibitory networks in the bone marrow of acute myeloid leukemia patients. | Cytometry A | 2024 | 39192598 | PubTator, text mining | PubMed |
| The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy. | Front Immunol | 2024 | 39156900 | PubTator, text mining | PubMed |
| PVR(CD155) as a potential immunological, diagnostic, and prognostic biomarker for pancreatic adenocarcinoma. | Asian J Surg | 2024 | 39127495 | PubTator, text mining | PubMed |
| Immunological Profiling of CD8+ and CD8- NK Cell Subpopulations and Immune Checkpoint Alterations in Early-Onset Preeclampsia and Healthy Pregnancy. | Int J Mol Sci | 2024 | 39125946 | PubTator, text mining | PubMed |
| Aspirin Inhibits Colorectal Cancer via the TIGIT-BCL2-BAX pathway in T Cells. | Int J Med Sci | 2024 | 39113892 | PubTator, text mining | PubMed |
| The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming. | Biomolecules | 2024 | 39062566 | PubTator, text mining | PubMed |
| C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial. | Nat Commun | 2024 | 39039086 | PubTator, text mining | PubMed |
| A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer. | Int Immunopharmacol | 2024 | 39029230 | PubTator, text mining | PubMed |
| Correlation Between Apical, Anterior, and Posterior Vaginal Wall Prolapse With Voiding Dysfunction: A Single Center Retrospective Cohort Study. | J Family Reprod Health | 2024 | 39011415 | PubTator, text mining | PubMed |
| Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma. | Clin Cancer Res | 2024 | 38990101 | PubTator, text mining | PubMed |
| Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia. | Cancer Immunol Immunother | 2024 | 38967649 | PubTator, text mining | PubMed |
| Predictors of Mortality in Pulmonary Hypertension-Associated Chronic Lung Disease. | J Clin Med | 2024 | 38929999 | PubTator, text mining | PubMed |
| Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma. | Nat Commun | 2024 | 38914547 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5817/papers?page=20